Entering text into the input field will update the search result below

Neuralstem FY14 results

  • Neuralstem (CUR +9%) FY14 results: Revenues: $0.02M (-80.0%); R&D Expense: $8.1M (+14.1%); SG&A: $9M (+69.8%); Operating Loss: ($17.4M) (-39.2%); Net Loss: ($22.6M) (-14.1%); Loss Per Share: ($0.26) (+3.7%); Quick Assets: $27.5M (+63.7%).
  • No guidance given.

Recommended For You

More Trending News

About PALI Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PALI--
Palisade Bio, Inc.